STatistically Assigned Response Criteria in Solid Tumors (STARCIST)

Cancer Imaging

Alex J. de Crespigny⁴  David S. Binns³  Timothy J. McCarthy¹  Sandra M. Sanabria-Bohorquez⁴  Rodney J. Hicks² 

[1] Clinical Imaging, Pfizer Global R&D, Groton, USAClinical Imaging, Pfizer Global R&D, Groton, USAClinical Imaging, Pfizer Global R&D, Groton, USA;The Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, AustraliaCancer Imaging, the Peter MacCallum Cancer Centre, East Melbourne, AustraliaThe Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, AustraliaThe Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, AustraliaCancer Imaging, the Peter MacCallum Cancer Centre, East Melbourne, AustraliaCancer Imaging, the Peter MacCallum Cancer Centre, East Melbourne, AustraliaThe Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, AustraliaCancer Imaging, the Peter MacCallum Cancer Centre, East Melbourne, Australia;The Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, AustraliaThe Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, AustraliaThe Sir Peter MacCallum Department of Oncology, the University of Melbourne, Parkville, Australia;Clinical Imaging, Genentech Inc, South San Francisco, USAClinical Imaging, Genentech Inc, South San Francisco, USAClinical Imaging, Genentech Inc, South San Francisco, USA

关键词: 18 F-FDG;    FDG-PET;    Drug response biomarkers;    Tumor response;    Signal detection;    Threshold estimation;    RECIST;    PERCIST;   

DOI  :  10.1186/s40644-015-0042-4

来源: e-MED Ltd

【 授权许可】

Unknown